Meningioma · line 1 · None

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Line of therapy	1
Track	local_therapy
Linked regimen	`None`

ID	`IND-MENINGIOMA-1L-RESECTION-RT`
Type	Indication
Status	reviewed 2026-05-11
Diseases	`DIS-MENINGIOMA`
Sources	`SRC-EANO-MENINGIOMA-2024` `SRC-NCCN-CNS-2025`

Notes

Coverage-enabling local-therapy indication for DIS-MENINGIOMA. Requires neurosurgery/radiation oncology co-lead signoff before clinical publication.

Used By

Algorithms

ALGO-MENINGIOMA-1L - ALGO-MENINGIOMA-1L

Indication

IND-PARATHYROID-CARCINOMA-1L-RESECTION - IND-PARATHYROID-CARCINOMA-1L-RESECTION
IND-VULVAR-VAGINAL-SCC-1L-WLE-SLNB - IND-VULVAR-VAGINAL-SCC-1L-WLE-SLNB